Non-myeloablative allogeneic stem cell transplantation (NST) for metastatic melanoma: nondurable chemotherapy responses without clinically meaningful graft-vs-tumor (GVT) effects.

R Childs; K Bradstock; D Gottlieb; D Blaise; E Leifer; N Geller; M Mohty; C Faucher; R Srinivasan; R Kefford; U Hegenbart; D Niederwieser; AJ Barrett

Non-myeloablative allogeneic stem cell transplantation (NST) for metastatic melanoma: nondurable chemotherapy responses without clinically meaningful graft-vs-tumor (GVT) effects.

R Childs, K Bradstock, D Gottlieb, D Blaise, E Leifer, N Geller, M Mohty, C Faucher, R Srinivasan, R Kefford, U Hegenbart, D Niederwieser, AJ Barrett

Research output: Contribution to journal › Meeting abstract

Original language	English
Article number	1661
Pages (from-to)	429A-429A
Number of pages	1
Journal	Blood
Volume	100
Issue number	11
Publication status	Published - 16 Nov 2002
Externally published	Yes
Event	44th Annual Meeting of the American-Society-of-Hematology - Philadelphia, United States Duration: 6 Dec 2002 → 10 Dec 2002

Cite this

Childs, R., Bradstock, K., Gottlieb, D., Blaise, D., Leifer, E., Geller, N., Mohty, M., Faucher, C., Srinivasan, R., Kefford, R., Hegenbart, U., Niederwieser, D., & Barrett, AJ. (2002). Non-myeloablative allogeneic stem cell transplantation (NST) for metastatic melanoma: nondurable chemotherapy responses without clinically meaningful graft-vs-tumor (GVT) effects. Blood, 100(11), 429A-429A. [1661].

Childs, R ; Bradstock, K ; Gottlieb, D ; Blaise, D ; Leifer, E ; Geller, N ; Mohty, M ; Faucher, C ; Srinivasan, R ; Kefford, R ; Hegenbart, U ; Niederwieser, D ; Barrett, AJ. / Non-myeloablative allogeneic stem cell transplantation (NST) for metastatic melanoma : nondurable chemotherapy responses without clinically meaningful graft-vs-tumor (GVT) effects. In: Blood. 2002 ; Vol. 100, No. 11. pp. 429A-429A.

@article{5adebece8eb8418d847d7c28a31e5db7,

title = "Non-myeloablative allogeneic stem cell transplantation (NST) for metastatic melanoma: nondurable chemotherapy responses without clinically meaningful graft-vs-tumor (GVT) effects.",

author = "R Childs and K Bradstock and D Gottlieb and D Blaise and E Leifer and N Geller and M Mohty and C Faucher and R Srinivasan and R Kefford and U Hegenbart and D Niederwieser and AJ Barrett",

year = "2002",

month = nov,

day = "16",

language = "English",

volume = "100",

pages = "429A--429A",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "11",

note = "44th Annual Meeting of the American-Society-of-Hematology ; Conference date: 06-12-2002 Through 10-12-2002",

}

Childs, R, Bradstock, K, Gottlieb, D, Blaise, D, Leifer, E, Geller, N, Mohty, M, Faucher, C, Srinivasan, R, Kefford, R, Hegenbart, U, Niederwieser, D & Barrett, AJ 2002, 'Non-myeloablative allogeneic stem cell transplantation (NST) for metastatic melanoma: nondurable chemotherapy responses without clinically meaningful graft-vs-tumor (GVT) effects.', Blood, vol. 100, no. 11, 1661, pp. 429A-429A.

Non-myeloablative allogeneic stem cell transplantation (NST) for metastatic melanoma : nondurable chemotherapy responses without clinically meaningful graft-vs-tumor (GVT) effects. / Childs, R; Bradstock, K; Gottlieb, D; Blaise, D; Leifer, E; Geller, N; Mohty, M; Faucher, C; Srinivasan, R; Kefford, R; Hegenbart, U; Niederwieser, D; Barrett, AJ.

In: Blood, Vol. 100, No. 11, 1661, 16.11.2002, p. 429A-429A.

Research output: Contribution to journal › Meeting abstract

TY - JOUR

T1 - Non-myeloablative allogeneic stem cell transplantation (NST) for metastatic melanoma

T2 - 44th Annual Meeting of the American-Society-of-Hematology

AU - Childs, R

AU - Bradstock, K

AU - Gottlieb, D

AU - Blaise, D

AU - Leifer, E

AU - Geller, N

AU - Mohty, M

AU - Faucher, C

AU - Srinivasan, R

AU - Kefford, R

AU - Hegenbart, U

AU - Niederwieser, D

AU - Barrett, AJ

PY - 2002/11/16

Y1 - 2002/11/16

M3 - Meeting abstract

VL - 100

SP - 429A-429A

JO - Blood

JF - Blood

SN - 0006-4971

IS - 11

M1 - 1661

Y2 - 6 December 2002 through 10 December 2002

ER -